Medtronic has received FDA clearance for a mobile app that allows patients to remotely forward data from their pacemakers with their physicians. The app is paired with a device, the MyCareLink Smart ...

DEFINE AFib Study Will Leverage Data from Medtronic Insertable Cardiac Monitors and Medtronic Discovery App™ with the Goal of Informing Atrial Fibrillation (AF) Management Strategies DUBLIN, June 29, ...

With a new smartphone app clearance from the FDA, Medtronic said it has all the pieces necessary to deliver a complete diabetes management system aimed at people taking multiple insulin injections per ...

More than a year after Medtronic released its MiniMed Connect system, which connects an insulin pump and affiliated CGM to a smartphone app, the company has launched an Android version of the MiniMed ...

Medtronic announced Tuesday that it has created a companion app to its pacemaker system whereby patients can use their smartphone or tablet to wirelessly transmit readings to doctors. This is the ...

New Smart MDI system will be the first system to deliver real-time, personalized insights on when and how much to dose including for missed or inaccurate mealtime doses. GALWAY, Ireland, Nov. 20, 2024 ...

With the COVID-19 pandemic still making it difficult to initiate studies in research centers, virtual clinical studies have become all the rage—and Medtronic is hopping on the bandwagon. The medtech ...

Medtronic (MDT) announced FDA clearance for its new InPen app featuring missed meal dose detection, paving the way for the launch of its Smart MDI system with the Simplera continuous glucose monitor, ...

Medical technology provider Medtronic and Fitbit joined forces to create a mobile app to help patients with diabetes better track their blood glucose levels and sync data from their wearable devices ...

Medtronic’s MiniMed Connect mobile accessory and app, which is used for glucose monitoring, is now available on Android devices. MiniMed Connect, which was initially launched on iOS in September 2015, ...

Medtronic disclosed that its Smart MDI system with continuous glucose monitoring capabilities is closer to launching after the Food and Drug Administration cleared an associated app. The medical ...

DUBLIN, -- Medtronic plc, the global leader in medical technology, today announced the initiation of the DEFINE AFib study, the company's first app-based research study. Using data collected from the ...